Quantcast

Latest Regeneron Pharmaceuticals Inc. Stories

2015-05-21 00:21:20

Includes study in patients who were inadequate responders to or intolerant of TNF-alpha inhibitors TARRYTOWN, N.Y. and PARIS, May 21, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.

2015-05-18 12:28:41

Phase 3 Clinical Trial in Uncontrolled Persistent Asthma Underway TARRYTOWN, N.Y. and PARIS, May 18, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.

2015-05-07 08:39:03

- First quarter 2015 EYLEA® (aflibercept) Injection global net sales increased 44% to $833 million (consisting of $541 million in the U.S.

2015-04-10 12:30:28

TARRYTOWN, N.Y., April 10, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.

2015-03-25 12:30:39

Diabetic retinopathy in patients with DME is the fourth approved indication for EYLEA in the U.S. TARRYTOWN, N.Y., March 25, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.

2015-03-15 12:20:27

- Robust and consistent LDL-C lowering demonstrated with Praluent(TM) in largest, double-blind, placebo-controlled trial of a PCSK9 inhibitor to date - PARIS and TARRYTOWN, N.Y., March 15,

2015-03-15 12:20:06

Robust and consistent LDL-C lowering demonstrated with Praluent(TM) in largest, double-blind, placebo-controlled trial of a PCSK9 inhibitor to date TARRYTOWN, N.Y.

2015-02-26 08:33:07

TARRYTOWN, N.Y., Feb. 26, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.

2015-02-18 16:27:04

In patients with moderate or worse vision loss at baseline, those treated with EYLEA gained, on average, an additional full line or more on an eye chart when compared to those treated with alternative

2015-02-18 08:31:18

View the Interactive Maps on www.CholesterolCounts.com for a Snapshot of Cholesterol Awareness Across the U.S. BRIDGEWATER, N.J. and TARRYTOWN, N.Y., Feb.


Word of the Day
chomage
  • Stoppage; cessation (of labor).
  • A standing still or idling (of mills, factories, etc.).
The word chomage comes into English from French.]
Related